Exploring how FLASH-Radiotherapy affects tumors and healthy tissue
Investigating the Effect of FLASH-Radiotherapy on Tumor and Normal Tissue
This study is looking at a new type of radiation therapy called FLASH-Radiotherapy to see if it can better treat head and neck cancer while causing fewer side effects, so patients might have a safer and more effective treatment option.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10834212 on NIH RePORTER |
What this research studies
This research investigates a new form of radiation therapy called FLASH-Radiotherapy, which delivers high doses of radiation to tumors in a very short time frame. The goal is to determine how this method impacts head and neck squamous cell carcinoma (HNSCC) and surrounding healthy tissues. By comparing FLASH-Radiotherapy to traditional radiation methods, the researchers aim to find ways to improve tumor control while reducing side effects. Patients may benefit from a more effective and less harmful treatment option if the research proves successful.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with head and neck squamous cell carcinoma who are seeking innovative treatment options.
Not a fit: Patients with other types of cancers or those not diagnosed with head and neck squamous cell carcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for head and neck cancer with fewer side effects.
How similar studies have performed: While FLASH-Radiotherapy is a novel approach, preliminary studies have shown promising results in reducing damage to healthy tissues compared to traditional methods.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Frank, Steven Jay — University of Tx Md Anderson Can Ctr
- Study coordinator: Frank, Steven Jay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.